Category: Events

June 5-8, 2023

Innovative programming around the current and future state of biotech. Including areas like therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital.

Find out more here!

Come meet with us!

International Society for Cell and Gene Therapy Annual meeting on May 31- June 3^rd, 2023.

With our core focus on cell and gene therapy translation, the ISCT Annual Meeting takes an integrative approach across ALL stakeholders to address key topics spanning translational research and preclinical development through to clinical trials, regulatory approvals, commercialization and ultimately patient access. Topics are curated to address the biggest bottlenecks in cell and gene therapy development.

 Please click on the meeting program for more information.

Come meet us there! 

May 16-20 

The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy. The meeting, which we’ve expanded to four full days in 2023, is the best place for people in the field to learn from the latest scientific research, stay up to date on new technologies, and make career-advancing connections with peers.

Originally designed as a venue for academic researchers to share their work, the Annual Meeting has grown to serve a wide community encompassing clinicians, bio-industry development, regulatory agencies, equipment manufacturers, patient advocates, and more.  Come meet us there!

The World Vaccine Congress, held on April 3-6, 2023, is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain.

If you are involved in vaccines or new to it because of the pandemic, this is the most important meeting you will be part of.

Come meet us there! 

Biocom California’s 13th Annual Global Life Science Partnering & Investor Conference is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. The meeting will be held in San Diego, on February 28th to March 2nd, 2023, where industry leaders will debate current trends, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers. 

North X Biologics is participating this conference. Come and book a meeting with us at contact@nxbio.com.

More details about this conference please click here. 

March 20^th-22^nd

Book a meeting with us here!

March 20^th-23^rd

Gene Therapy For Rare Disorders

The 6th Annual Gene Therapy for Rare Disorders 2023 Summit remains devoted to showcasing the top case studies and strategic learnings from the past year. With an expert speaking faculty devoted to bringing safer and more effective gene therapies to rare disease patients, key questions will be answered on how best the field can overcome regulatory, clinical, manufacturing and pricing bottlenecks to progress gene therapies into and through the clinic. Book a meeting with us here!

February 15^th 2023

#CGTI Leaders Summit 2023

An exclusive and private gathering that focuses on bringing together industry captains, decision-makers and intellectual vanguards across cell and gene therapy to network, learn and advance. This is an in-person only event. Book a meeting with us here! 

Advanced Therapies Week is an event like no other.

With networking opportunities taking place from morning to night, we provide attendees with an outstanding experience that entails thought-provoking content, high-profile speakers, and unmissable networking events. We bring together the advanced therapies field in the most memorable way, and we guarantee you’ll want to be involved.  Book a meeting with us here!

Xintela and NorthX Biologics announce that they have signed a collaborative framework agreement to jointly accelerate the development of advanced therapeutics (ATMP) by leveraging the companies’ complementary skills and resources in ATMP development and GMP manufacturing. Projects to be initiated within the framework of the collaboration include, among other things, product and process development, quality control and increased expansion capacity for manufacturing ATMPs.

“This is a very interesting opportunity for us. Xintela has developed the unique stem cell product XSTEM, which is now in clinical development, and has strong expertise in process development and GMP manufacturing of stem cells and other ATMPs. Together with NorthX Biologics and their manufacturing capacity, we can further expand and also broaden our ATMP business”, says Evy Lundgren-Åkerlund, CEO of Xintela.
“This collaboration is another step in the right direction towards becoming a leading solution provider in the cell and gene therapy space, adding to the solid expertise NorthX has already gained from +30 years of advanced biological GMP manufacturing. I am happy to work with Xintela and look forward to our relationship going forward,” says Helena Strigård, CEO of NorthX Biologics.